Listed

Xtant Medical Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 14, 2014 and accepted by EDGAR at Aug 14, 2014, 13:13 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-04-01 to 2014-06-30$8.9mus-gaap:SalesRevenueNet
Revenue6 months2014-01-01 to 2014-06-30$17.8mus-gaap:SalesRevenueNet
Cost of revenue3 months2014-04-01 to 2014-06-30$3.3mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2014-01-01 to 2014-06-30$6.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2014-04-01 to 2014-06-30$5.6mus-gaap:GrossProfit
Gross profit6 months2014-01-01 to 2014-06-30$11.1mus-gaap:GrossProfit
Research and development3 months2014-04-01 to 2014-06-30$322.3kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-01-01 to 2014-06-30$576.9kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-04-01 to 2014-06-30−$1.3mus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$2.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-04-01 to 2014-06-30$1.4mus-gaap:InterestExpense
Interest expense6 months2014-01-01 to 2014-06-30$2.7mus-gaap:InterestExpense
Net income3 months2014-04-01 to 2014-06-30−$1.9mus-gaap:NetIncomeLoss
Net income6 months2014-01-01 to 2014-06-30−$6.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-04-01 to 2014-06-30−$0.35us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30−$1.11us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-04-01 to 2014-06-30−$0.35us-gaap:EarningsPerShareBasic
Basic EPS6 months2014-01-01 to 2014-06-30−$1.11us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-04-01 to 2014-06-305,514,694 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2014-01-01 to 2014-06-305,447,204 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure6 months2014-01-01 to 2014-06-30$115.2kus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2014-06-30$3.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-30$19.4mus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$28.4mus-gaap:Assets
Current liabilitiesAt period end2014-06-30$9.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-30$36.4mus-gaap:Liabilities
Long-term debtAt period end2014-06-30$20.0mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2014-06-30$49.2kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2014-06-30−$8.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-14-060948. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.